Vimarsana
Biggest News Aggregation in the World

Page 5 - Lymph Node News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymph Node. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymph Node Today - Breaking & Trending Today

Release 0.08 - Afterlife news - Disinfection - Vimarsana News

Release 0.08 - Afterlife news - Disinfection

Death is not the end, but you may wish it was when finding your body consumed and repurposed by the infection. Yet... Your consciousness remains. Try your best to influence the infection, either making it stronger or weakening it and perhaps even destroying...

Source: moddb.com
Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer - Vimarsana News

Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer

For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

Resident Tregs found to remain in certain lymph nodes for a long time - Vimarsana News

Resident Tregs found to remain in certain lymph nodes for a long time

The immune system is fast when it comes to fighting viruses, bacteria and other pathogens. But it also has to know when not to attack - for example, harmless substances such as pollen or house dust, which otherwise trigger allergic reactions.

U.S. FDA Grants Paige Breakthrough Device Designation for Cancer Detection in Breast Lymph Nodes - Vimarsana News

U.S. FDA Grants Paige Breakthrough Device Designation for Cancer Detection in Breast Lymph Nodes

Paige Lymph Node is recognized by the FDA as a breakthrough device to assist pathologists in the detection of breast cancer metastases in lymph node tissue 

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma - Vimarsana News

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.